Search

Christopher P. Jones

Examiner (ID: 5555, Phone: (571)270-7383 , Office: P/1776 )

Most Active Art Unit
1776
Art Unit(s)
1776, 1797
Total Applications
1840
Issued Applications
1378
Pending Applications
121
Abandoned Applications
373

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14929895 [patent_doc_number] => 20190300585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => DENDRITIC-CELL-TARGETED PEPTIDE, FUSION PEPTIDE UTILIZING SAID PEPTIDE, AND VACCINE UTILIZING SAID FUSION PEPTIDE [patent_app_type] => utility [patent_app_number] => 16/335625 [patent_app_country] => US [patent_app_date] => 2017-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335625 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335625
Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide Sep 20, 2017 Issued
Array ( [id] => 12624504 [patent_doc_number] => 20180099998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/699482 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699482 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/699482
None Sep 7, 2017 Issued
Array ( [id] => 17741449 [patent_doc_number] => 11389494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Composition for suppressing or improving eye fatigue [patent_app_type] => utility [patent_app_number] => 16/331849 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14598 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331849
Composition for suppressing or improving eye fatigue Sep 7, 2017 Issued
Array ( [id] => 15239687 [patent_doc_number] => 20190374629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS [patent_app_type] => utility [patent_app_number] => 16/331863 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331863 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331863
THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS Sep 6, 2017 Pending
Array ( [id] => 19519851 [patent_doc_number] => 12121549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-22 [patent_title] => Application of [patent_app_type] => utility [patent_app_number] => 16/642741 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8823 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642741 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/642741
Application of Aug 28, 2017 Issued
Array ( [id] => 17185227 [patent_doc_number] => 20210332112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE [patent_app_type] => utility [patent_app_number] => 16/325710 [patent_app_country] => US [patent_app_date] => 2017-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325710 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325710
STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE Aug 14, 2017 Abandoned
Array ( [id] => 14375243 [patent_doc_number] => 20190161534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE [patent_app_type] => utility [patent_app_number] => 16/321528 [patent_app_country] => US [patent_app_date] => 2017-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321528 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321528
ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE Aug 10, 2017 Abandoned
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 16862802 [patent_doc_number] => 11021534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-01 [patent_title] => Mycobacterial antigen composition [patent_app_type] => utility [patent_app_number] => 15/672085 [patent_app_country] => US [patent_app_date] => 2017-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 28697 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672085 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/672085
Mycobacterial antigen composition Aug 7, 2017 Issued
Array ( [id] => 17392501 [patent_doc_number] => 11241489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Multivalent pneumococcal polysaccharide-protein conjugate composition [patent_app_type] => utility [patent_app_number] => 16/322726 [patent_app_country] => US [patent_app_date] => 2017-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 16115 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322726 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322726
Multivalent pneumococcal polysaccharide-protein conjugate composition Aug 3, 2017 Issued
Array ( [id] => 14980619 [patent_doc_number] => 10444217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-10-15 [patent_title] => Rapid analysis for cyanobacterial toxins [patent_app_type] => utility [patent_app_number] => 15/667822 [patent_app_country] => US [patent_app_date] => 2017-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11941 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667822 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/667822
Rapid analysis for cyanobacterial toxins Aug 2, 2017 Issued
Array ( [id] => 12049878 [patent_doc_number] => 20170326223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)' [patent_app_type] => utility [patent_app_number] => 15/660455 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25893 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660455 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/660455
Surface exposed Jul 25, 2017 Issued
Array ( [id] => 14715555 [patent_doc_number] => 20190248841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => Immunogenic Composition [patent_app_type] => utility [patent_app_number] => 16/308972 [patent_app_country] => US [patent_app_date] => 2017-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37703 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308972 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308972
Immunogenic Composition Jun 14, 2017 Abandoned
Array ( [id] => 14621467 [patent_doc_number] => 20190224101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => HUMAN ANTIBODY SPECIFICALLY BINDING TO ACNE BACTERIA USING PHAGE DISPLAY TECHNIQUE, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/309582 [patent_app_country] => US [patent_app_date] => 2017-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309582 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/309582
Human antibody specifically binding to acne bacteria using phage display technique, and use thereof Jun 12, 2017 Issued
Array ( [id] => 16360987 [patent_doc_number] => 20200317738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => METHODS FOR INCREASING PROLIFERATION OF MAMMALIAN CELLS [patent_app_type] => utility [patent_app_number] => 16/303483 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/303483
METHODS FOR INCREASING PROLIFERATION OF MAMMALIAN CELLS May 25, 2017 Abandoned
Array ( [id] => 15898421 [patent_doc_number] => 20200148729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections [patent_app_type] => utility [patent_app_number] => 16/098911 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24826 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098911 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098911
Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections May 18, 2017 Abandoned
Array ( [id] => 15145115 [patent_doc_number] => 20190351035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => VACCINE AGAINST TRYPANOSOMA CRUZI INFECTION [patent_app_type] => utility [patent_app_number] => 16/311597 [patent_app_country] => US [patent_app_date] => 2017-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/311597
VACCINE AGAINST TRYPANOSOMA CRUZI INFECTION May 1, 2017 Abandoned
Menu